4AB

AbbVie, Inc. · TRADEGATE:4AB

264.20 EUR0.6000 +0.23%

AbbVie, Inc. (TRADEGATE:4AB) last traded at 264.20 EUR, up 0.23% on the day. Over the past year the stock is up 34.93%. Its 52-week range is 162.90 to 270.10. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open262.60

Day range261.20 – 264.20

52-week range162.90 – 270.10

Volume622

Average volume (10 days)1.88 K

Market cap (USD)521.11 B

P/E51.44

EPS (TTM) (USD)5.82

Dividend yield2.32%

Beta (1 year)0.0129

Revenue (TTM) (USD)66.01 B

Employees57.00 K

Performance

+3.93%1 week

+14.62%1 month

+23.11%3 months

+50.93%6 months

+35.49%Year to date

+34.93%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Weekly Recap: Q3 financial gains and Skyrizi Crohn’s FDA approvalTradingView · 02 Nov 2026
The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of RevenueGuruFocus · 30 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.